简体
简体中文
繁體中文

VanEck社交情绪ETF BUZZ

交易中 03-25 11:45:01 美东时间

30.00

+0.460

+1.56%

华盛通华盛通
立即下载
  • 最 高30.375
  • 今 开30.175
  • 成交量 9.02万股
  • 最 低 29.79
  • 昨 收 29.54
  • 总市值 9075.00万
  • 52周最高 39.585
  • 市盈率 --
  • 换手率 2.98%
  • 52周最低 18.8204
  • 委 比 1.49%
  • 总股本 302.50万
  • 历史最高 39.585
  • 量 比 1.89
  • 振 幅 1.98%
  • 历史最低 11.4787
  • 每 手 1
  • 风险率 4.39%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • BUZZ-Liberty Energy drops after planned $450 mln convertible offering announced

    BUZZ-Liberty Energy drops after planned $450 mln convertible offering announced ** Oilfield services firm Liberty Energy LBRT.N shares down 6.6% at $27.75 before the bell as it seeks more capital ** Denver, Colorado-based LBRT announces private offering of $450 mln 6-yr convertible bonds (CBs) ** Co

    今天 20:56

  • BUZZ-Enliven gains after Jones raises PT on increased takeover appeal

    BUZZ-Enliven gains after Jones raises PT on increased takeover appeal ** Shares of drug developer Enliven Therapeutics ELVN.O rise 14.13% to $35.55 premarket ** Jones Trading raises PT to $45 from $35 and reiterates a "buy" rating ** Brokerage says Merck's MRK.N $6.7 billion deal to buy rival Terns

    今天 20:56

  • BUZZ-KBH Home down as demand weighs on Q1 results, 2026 forecast

    BUZZ-KBH Home down as demand weighs on Q1 results, 2026 forecast ** Shares of homebuilder KBH Home KBH.N down 1% at $52.8 premarket ** The company on Tuesday posted first-quarter diluted earnings per share of 52 cents vs $1.49 for the same period last year ** Co's Q1 revenues were down 23% to $1.08

    今天 19:54

  • BUZZ-Street View: Karyopharm's cancer drug trial results limit regulatory odds

    BUZZ-Street View: Karyopharm's cancer drug trial results limit regulatory odds ** Karyopharm Therapeutics KPTI.O said on Tuesday its therapy led to significant reduction in spleen size in a late-stage study of patients with myelofibrosis, a rare blood cancer, meeting only one of its two main goals *

    今天 19:49

  • BUZZ-Anavex withdraws EU filing for Alzheimer's drug, shares fall

    BUZZ-Anavex withdraws EU filing for Alzheimer's drug, shares fall ** Shares of biotech firm Anavex Life Sciences AVXL.O fall 18% to $3.43 premarket ** Co says it has withdrawn its EU application for experimental Alzheimer's drug, blarcamesine, after regulators said they could not support approval **

    今天 19:47

  • BUZZ-Chewy rises after Q4 profit beat

    BUZZ-Chewy rises after Q4 profit beat ** Online pet products retailer Chewy's CHWY.N shares rise 7.3% to $25.18 premarket ** Co reports Q4 adj. EPS of $0.27, well above analysts' estimates of $0.09 - LSEG data ** However, Q4 net sales of $3.26 billion comes in below estimates of $3.29 billion ** CHW

    今天 19:42

  • BUZZ-Honeywell, Lockheed gain on new US defense production agreements

    BUZZ-Honeywell, Lockheed gain on new US defense production agreements ** Shares of industrial conglomerate Honeywell HON.O rise 1.3% to nearly $225 and defense firm Lockheed Martin LMT.N marginally up 0.4% at about $613 premarket ** Honeywell Aerospace has signed a supplier framework agreement with

    今天 19:40

  • BUZZ-Terns Pharma climbs on Merck's $6.7 bln takeover deal

    BUZZ-Terns Pharma climbs on Merck's $6.7 bln takeover deal Updates ** Shares of biotech firm Terns Pharma TERN.O up 5% at $ 52.54 premarket ** Merck MRK.N says it will buy Terns in a deal valued at about $6.7 billion ** Merck will pay $53 per share in cash, a premium of 6% to TERN stock's last close

    今天 19:02

  • BUZZ-ADMA Biologics rises after rejecting short-seller report

    BUZZ-ADMA Biologics rises after rejecting short-seller report ** Shares of biotech firm ADMA Biologics ADMA.O rise about 3% to $11.63 premarket ** ADMA rejects a negative report by Culper Research, which has a short position in the stock ** Culper on March 24 accused the company of inflating its sal

    今天 18:43

  • BUZZ-Terns Pharma jumps after report Merck nears $6 bln takeover

    BUZZ-Terns Pharma jumps after report Merck nears $6 bln takeover ** Shares of biotech firm Terns Pharma TERN.O up 12.5% at $56.2 premarket ** Financial Times reports, citing people familiar with the matter, that drugmaker Merck MRK.N is nearing a roughly $6 bln all-cash deal to acquire TERN ** Negot

    今天 18:22